Search

everythinglearnresearchcommunity

for

Search:↓

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Baricitinib may help treat frontal fibrosing alopecia and facial papules.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

Hepatitis C treatment may cause frontal fibrosing alopecia.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Finasteride may cause floppy-iris syndrome during cataract surgery, so check patients' medical history.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

Alpha-blocker therapy may not be needed long-term when combined with finasteride for BPH.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

BPH treatments can cause sexual side effects affecting quality of life.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.